News About: Pharm. Industry
Eximbank vows more support for pharmaceutical firms entering emerging markets
Export-Import Bank of Korea will step up support for pharmaceutical companies entering emerging markets, the bank’s chairman and president Kim Yong-hwan said Thursday.
“In order to secure future growth engines for ...
Hospitals to address delayed drug bills
The Korea Hospital Association president Kim Yoon-soo pledged to shorten a longer payment turnover over drug bills during a government’s regular economic meeting Thursday.
He said that all hospitals will make all-o...
KPMA names new president
The Korea Pharmaceutical Manufacturers Association (KPMA) announced Wednesday that Kim Won-bae, CEO of Dong-A Pharmaceutical, will lead its association based on his background in the country, together with the incumbe...
Local drug makers kindling strategic alliance flame
Korea’s major pharmaceutical firms are fervently seeking strategic alliances with a number of multinational pharmaceutical firms using its strong sales and marketing force in a bid to boost their sluggish sales.
Ko...
Market value by foreign ownership tops 1.8 trillion won mark
Korea’s 57 pharmaceutical companies that went public on the local bourse saw their combined foreign ownership reach 5.2 percent to 1.8 trillion won as of August 21, Yakup.com., a website tracking Korean drug makers, r...
Silent axes swinging in pharmaceutical firms
Korean pharmaceutical companies are pushing forward with corporate restructuring as they already feel the pinch of falling sales and profits caused by the government-mandated cuts in drugs prices in April.
Restruct...
Multinational drug firms bite bigger share
With foreign drug makers taking a bigger share of the domestic prescription market taking a bigger share of the domestic prescription market, Korea's pharmaceutical companies have seen falling market share.
Korean ...
Pharmaceutical firms pile up cash reserves
Korean drug companies piled up cash reserves in the first half of this year, as they refrained from investing amid the market downturn stemming from the impact of the drug price cuts in April.
According to a report...
Dong-A beats Kwangdong in energy drinks
Dong-A Pharmaceutical has taken a large lead over rival Kwangdong in energy drinks, reaping 82.4 billion won in Bacchus sales in the first half of this year.
By contrast, Kwangdong Pharmaceutical only reported 47.1...
KFDA approves new treatment option for late-stage breast cancer
The Korea Food and Drug Administration approved last Friday Halaven (eribulin mesylate) to treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease...
